Global X Interest Rate Volatility & Inflation Hedge ETF
IRVH
1 hedge funds and large institutions have $8.35K invested in Global X Interest Rate Volatility & Inflation Hedge ETF in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.
19,323% more capital invested
Capital invested by funds: $43 → $8.35K (+$8.31K)
0.58% more ownership
Funds ownership: 0% → 0.58% (+0.58%)
0% more funds holding
Funds holding: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$8.51K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$43 |
IRVH Hedge Fund Activity: Q4 2025 in Review
1 of the 8,238 institutional investors tracked by Wall St. Rank reported a position in Global X Interest Rate Volatility & Inflation Hedge ETF (IRVH) for Q4 2025, worth a combined $8.35K — up 19,323% from $43 a quarter earlier.
Fund positioning in IRVH was balanced in Q4 2025: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $8.51K. The largest seller was Morgan Stanley, exiting entirely with an estimated $43 sold.
- 1 institutional investor held Global X Interest Rate Volatility & Inflation Hedge ETF (IRVH) as of Q4 2025, unchanged from Q3 2025.
- Funds reported $8.35K of Global X Interest Rate Volatility & Inflation Hedge ETF stock for Q4 2025, up 19,323% quarter-over-quarter.
- 1 fund opened new Global X Interest Rate Volatility & Inflation Hedge ETF positions in Q4 2025 and 1 closed out, a net change of 0 holders.
- The largest Global X Interest Rate Volatility & Inflation Hedge ETF buyer in Q4 2025 was UBS Group, an estimated $8.51K added.
- The largest Global X Interest Rate Volatility & Inflation Hedge ETF seller in Q4 2025 was Morgan Stanley, an estimated $43 sold.
Based on aggregated 13F filings for Q4 2025.